Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Humana (NYSE:HUM) with a Buy recommendation. Analyst Price Forecast Suggests 4.77% Upside As of April 2, 2025, the average ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

Medical Properties Trust (MPT), a healthcare-focused real estate investment trust (REIT), faced ... coupled with a favorable financial outlook, have positioned CVS positively, despite a backdrop ...

Substantial bets on investment themes or sectors—such as ... For example, it began building a position in health insurance provider Humana in early 2024. While the team acknowledges the company ...

Morgan Stanley raised the firm’s price target on Humana (HUM) to $290 from $285 and keeps an Equal Weight rating on the shares. While policy ...

Baird raised the firm’s price target on Humana (HUM) to $300 from $270 and keeps a Neutral rating on the shares. The firm sees minimal ...

Director at CBRE Investment Management as we discuss the outlook for multifamily investment. We’ll dive into: ...

The stock's fall snapped a five-day winning streak.

Tenet Healthcare (THC) stock was named as Best Idea at Guggenheim as the firm launched the coverage of 11 healthcare services ...

Anticipation is growing for Citigroup (NYSE: C) to release its first-quarter earnings on April 15. The banking giant's shares ...

Commissions do not affect our editors' opinions or evaluations. Investing in real estate can help you build wealth and achieve financial freedom. Before you take the plunge, it’s essential to ...